These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1392 related articles for article (PubMed ID: 8727307)
1. Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis. De Wit PE; Van Muijen GN; De Waal RM; Ruiter DJ Curr Opin Oncol; 1996 Mar; 8(2):143-51. PubMed ID: 8727307 [TBL] [Abstract][Full Text] [Related]
2. Properties of metastasizing and nonmetastasizing human melanoma cells. van Muijen GN; Danen EH; de Vries TJ; Quax PH; Verheijen JH; Ruiter DJ Recent Results Cancer Res; 1995; 139():105-22. PubMed ID: 7597284 [TBL] [Abstract][Full Text] [Related]
3. Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. Danen EH; Van Muijen GN; Ruiter DJ Cancer Surv; 1995; 24():43-65. PubMed ID: 7553662 [TBL] [Abstract][Full Text] [Related]
4. Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target. Fröhlich E Cell Mol Life Sci; 2010 Dec; 67(23):3947-60. PubMed ID: 20686912 [TBL] [Abstract][Full Text] [Related]
5. The plasminogen activation system in melanoma cell lines and in melanocytic lesions. de Vries TJ; van Muijen GN; Ruiter DJ Melanoma Res; 1996 Apr; 6(2):79-88. PubMed ID: 8791264 [TBL] [Abstract][Full Text] [Related]
20. Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions. Dundr P; Simon K; Němejcová K; Bártů M; Tichá I; Michálková R; Jakša R; Věcková Z; Kodet O Melanoma Res; 2019 Apr; 29(2):157-162. PubMed ID: 30422880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]